Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, December 13, 2013
Thomas Feinberg, PhD, Catalent Pharma Solutions’ Director of Development and Analytical Solutions, is to present at the forthcoming “Suitability and Compatibility for Packaging and Delivery Systems
read more
Thursday, November 21, 2013
Pharmaceutical Product Development, LLC (PPD) today announced it has appointed Andrew Cunningham, Ph.D., as vice president of central laboratory services. Dr. Cunningham brings extensive biopharmaceutical industry experience to PPD’s central ...
read more
Tuesday, November 19, 2013
Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced that Adrian Raiche, Ph.D. has joined the company as Director of Formulation Development.
read more
Friday, November 15, 2013
ordenPharma acquired Ancora Pharmaceuticals, located in Woburn, MA, USA. Ancora’s unique carbohydrate synthesis technology platform and chemistry research facilities perfectly complement CordenPharma’s capabilities in the manufacture and supply of ...
read more
Monday, November 11, 2013
Cytovance Biologics, a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces Jesse McCool as Vice President of Microbial Services.
read more
Wednesday, November 06, 2013
The strategies and timing of outsourcing pharmaceutical development processes to a contract testing laboratory will be the focus of a mini-workshop at the 2013 AAPS Annual Meeting and Exposition on Nov. 12, 2013.
read more
Thursday, October 31, 2013
“The launch of the new brand logo is an outward sign of an important transformation that’s been ongoing for the past couple of years,” said John D. Bucksath, President and CEO. “The entire organization has worked very hard to get where we are today. ...
read more
Thursday, October 31, 2013
Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, today announces a three-year extension of its integrated contract drug discovery agreement with Genentech, a member of ...
read more
Thursday, October 31, 2013
The U.S. regulatory landscape changed dramatically 10 years ago. In 2003, legal roadblocks to the 505(b)(2) approval pathway were resolved, making it a practical alternative route for drug development. That same year, Ken Phelps and Ruth Stevens ...
read more
Friday, September 20, 2013
Coldstream Laboratories, Inc., a provider of parenteral manufacturing and sterile drug product development services, has announced that Pamela Savoy has joined the company as Director of Business Development. In this position, Ms. Savoy will be ...
read more
Tuesday, September 17, 2013
Global pharmaceutical chemistry leader Cambridge Major Laboratories, Inc. (CML) is pleased to announce the appointment of Dr. Mark Sawicki as Chief Business Officer. With executive leadership responsibility for the global sales and marketing ...
read more
Thursday, August 22, 2013
A workshop to discuss ways of improving the quality of drugs entering into the preclinical stage of development will be led by Ciriaco Maraschiello, PhD, director of drug discovery and translational medicines for Harlan Contract Research Services (...
read more
To stay ahead of the diverse and evolving needs of its global customer base, Quintiles today announced it has signed an agreement to acquire Novella Clinical (Novella), a full-service clinical research organization (CRO) focused primarily on emerging...
read more
Thursday, August 15, 2013
Nuevolution A/S today announced that it has entered into a scientific collaboration with Duke University, the Howard Hughes Medical Institute, and Lexicon Pharmaceuticals, Inc. for the investigation of the biological mechanism of action of a ...
read more
Pharmaceutical Product Development, LLC (PPD) today announced it has appointed David Johnston, Ph.D., as executive vice president of global laboratory services. Dr. Johnston directs PPD’s industry-leading, comprehensive laboratory services, including...
read more